Q1 2024 · 13F-HR
FCPM III SERVICES B.V.holdings as filed
Filed 2024-05-03 · accession 0001802806-24-000028
$707.3M
Reported value
6
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $279.8M | 39.6% | 11,831,461 | Common | SHARED |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $222.7M | 31.5% | 7,845,364 | Common | SHARED |
| 29286M105 | — | ENGENE HOLDINGS INC | $147.1M | 20.8% | 8,677,951 | Common | SHARED |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $39.8M | 5.62% | 4,866,449 | Common | SHARED |
| 29286M113 | — | ENGENE HOLDINGS INC | $15.0M | 2.12% | 2,878,148 | Common | SHARED |
| 00449L102 | 698 | ACHILLES THERAPEUTICS PLC | $3.0M | 0.42% | 2,390,050 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.